{
  "ptid_time": "053_S_5070_2013-01-31",
  "img_path": "/data/qiuhui/data/adni/images/053_S_5070/2013-01-31/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 100,052 mm³, 159.8% above the reference mean. With a Z-score of 3.83 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 7,185 mm³, 4.9% below the reference mean. With a Z-score of -0.48 (31.5th percentile), this represents normal volume ; whole brain volume measures 1,067,500 mm³, 1.1% below the reference mean. With a Z-score of -0.14 (44.3th percentile), this represents normal volume ; entorhinal cortex volume measures 3,820 mm³, 6.8% below the reference mean. With a Z-score of -0.46 (32.1th percentile), this represents normal volume ; fusiform gyrus volume measures 15,789 mm³, 16.2% below the reference mean. With a Z-score of -1.38 (8.4th percentile), this represents mild atrophy; middle temporal gyrus volume measures 17,462 mm³, 18.2% below the reference mean. With a Z-score of -1.63 (5.1th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 71.2 years. Gender is Male. Education: 15 years. Handedness: Right. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Endocrine-Metabolic; Malignancy. MMSE: 26.0. MoCA: 18.0. Logical Memory: 1.0. Laboratory findings: MCHC: 36.00 (significant elevated); WBC: 9.07 (significant elevated); Neutrophils: 6.10 (significant elevated); Total Bilirubin: 0.90 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.64 SUVR (profound elevated); Amyloid beta: 489.70 pg/mL (mild reduced); Total tau: 203.80 pg/mL (normal ); Phosphorylated tau: 19.45 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound ventricular enlargement (Z-score 3.83) and moderate atrophy in the middle temporal gyrus (Z-score -1.63), along with mild fusiform gyrus atrophy (Z-score -1.38). The MMSE is borderline (26), but the MoCA (18) suggests significant cognitive impairment. Elevated AV45 (amyloid PET) supports amyloid pathology, while normal hippocampal volume argues against advanced neurodegeneration.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive, with neurodegeneration in temporal regions but preserved hippocampal volume).  \n\n**Confidence:** **Medium** (clear structural and biomarker abnormalities, but MCI rather than dementia due to preserved hippocampal volume and lack of severe functional decline).  \n\n*Note: A clinical assessment of daily functioning would help confirm whether this meets dementia criteria (e.g., ADL impairment).*",
  "timestamp": "2025-07-26T08:01:08.947252"
}